Thimble Point (THMA) and Pear Therapeutics Arrange Backstop Funding

thimble-point-pear

Thimble Point (THMA) and Pear Therapeutics Arrange Backstop Funding

Nov 15, 2021 INTEL by Kristi Marvin

Thimble Point Acquisition Corp, Inc. (NASDAQ: THMA) and Pear Therapeutics, announced this morning that they have arranged an “up to $50 million” backstop funding ahead of their scheduled shareholder vote later this month. THMA previously disclosed a $125 million PIPE at combination announcement with a large roster of investors that includes 5AM Ventures, Arboretum Ventures,
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.